Correlation between PD-L1 expression and clinical pathology, immunobiological markers, and prognosis in gastroenteropancreatic neuroendocrine neoplasms: a systematic review and meta-analysis
Frontiers in Immunology · 2026
DOI: 10.3389/fimmu.2026.1772011 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Immunology, 2026. Verfasst von Qiming Zheng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery/Transplantation, First Central Hospital of Tianjin Medical University, Tianjin, China. Hauptthemen laut MEDLINE: B7-H1 Antigen, Pancreatic Neoplasms, Neuroendocrine Tumors, Intestinal Neoplasms. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Advanced gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) have limited therapeutic options. The role of programmed death-ligand 1 (PD-L1) in their clinicopathology, immune markers, and prognosis remains controversial. This meta-analysis aimed to systematically clarify these relationships.
Methods
We searched Medline/PubMed, Web of Science, Embase, and Cochrane Library from inception to November 2025 for studies on PD-L1 expression in GEP-NENs. Two researchers independently extracted data and assessed quality via Newcastle-Ottawa Scale (NOS). Pooled analyses were conducted using Stata 17.0, with odds ratio (OR)/hazard ratio (HR) and 95% confidence interval (CI) as effect indicators, and fixed/random-effects models chosen by heterogeneity.
Results
A total of 22 studies involving 1,872 patients (17 high-quality and 5 moderate-quality) were included. High PD-L1 expression was significantly associated with higher tumor grade (OR = 3.78, 95% CI:2.04-7.01; p<0.001), poorer differentiation (OR = 2.80, 95% CI:1.18-6.65; p=0.020), increased PD-1 expression (OR = 4.15, 95% CI:2.16-7.99; p<0.001), and shorter overall survival (HR = 1.66, 95% CI:1.32-2.10; p<0.001). No significant associations were found with sex, age, histological type, tumor stage, invasion, metastasis, CD8+ T cell/FOXP3+ T cell infiltration, or mismatch repair (MMR) status. No publication bias existed.
Conclusion
High PD-L1 expression in GEP-NENs correlates with aggressive clinicopathological features, PD-1 upregulation, and unfavorable prognosis. PD-L1 may serve as a prognostic biomarker and therapeutic target for immune checkpoint inhibitors, particularly in high-grade/poorly differentiated tumors. Large-scale prospective studies are needed for validation. Systematic review registration https://www.crd.york.ac.uk/PROSPERO , identifier CRD420251048602.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery/Transplantation, First Central Hospital of Tianjin Medical University, Tianjin, China.
- Department of Liver Transplantation, Tianjin First Central Hospital, Tianjin, China.
- Tianjin Key Laboratory of Molecular Diagnosis and Treatment of Liver Cancer, Tianjin First Center Hospital, Tianjin, China.
- Tianjin Key Laboratory for Organ Transplantation, Tianjin First Center Hospital, Tianjin, China.
- Department of Hepatobiliary Pancreatic Spleen Surgery, Baoji People's Hospital, Baoji, Shaanxi, China.
- Institute of Transplantation Medicine, Nankai University, Tianjin, China.
Zitieren
APA
Zheng, Q., Jin, S., Xie, X., Guo, Q., Chen, C., & Jiang, W. (2026). Correlation between PD-L1 expression and clinical pathology, immunobiological markers, and prognosis in gastroenteropancreatic neuroendocrine neoplasms: a systematic review and meta-analysis. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2026.1772011
Vancouver
Zheng Q, Jin S, Xie X, Guo Q, Chen C, Jiang W. Correlation between PD-L1 expression and clinical pathology, immunobiological markers, and prognosis in gastroenteropancreatic neuroendocrine neoplasms: a systematic review and meta-analysis. Frontiers in Immunology. 2026. doi:10.3389/fimmu.2026.1772011
BibTeX
@article{Zheng2026,
author = {Zheng, Qiming and Jin, Shangbo and Xie, Xinyue and Guo, Qingjun and Chen, Chiyi and Jiang, Wentao},
title = {Correlation between PD-L1 expression and clinical pathology, immunobiological markers, and prognosis in gastroenteropancreatic neuroendocrine neoplasms: a systematic review and meta-analysis},
journal = {Frontiers in Immunology},
year = {2026},
doi = {10.3389/fimmu.2026.1772011}
}
EUVIMED